Invert vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 40)
Invert logo

Invert

EmergingHealthcare

General

AI bioprocessing data platform for cellular agriculture and synthetic biology optimizing fermentation with 90% data reduction; $20.6M raised at $5M revenue serving industrial biotech scale-up.

AI VisibilityBeta
Overall Score
C40
Category Rank
#382 of 596
AI Consensus
76%
Trend
up
Per Platform
ChatGPT
34
Perplexity
40
Gemini
45

About

Invert is a San Francisco-based AI software company providing data analytics and process optimization infrastructure for biomanufacturing — enabling bioprocessing teams at cellular agriculture, synthetic biology, and industrial biotech companies to manage, analyze, and optimize their bioprocess data in real-time. Founded and backed with $20.6 million raised, Invert generates $5 million in revenue and employs 40 people, applying meta-learning approaches that reportedly reduce new data requirements for process optimization by up to 90%.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

40
Overall Score
88
#382
Category Rank
#3
76
AI Consensus
78
up
Trend
stable
34
ChatGPT
83
40
Perplexity
87
45
Gemini
85
40
Claude
90
40
Grok
92

Key Details

Category
General
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.